MultiCell Technologies Inc. (MCET.OB) Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
5/16/2013 10:22:14 AM
More...
|
MultiCell Technologies Inc. (MCET.OB) Delivered Presentation at 2012 ASCB Meeting
12/27/2012 7:16:28 AM
More...
|
Grant G. Miller Joins Board of MultiCell Technologies Inc. (MCET.OB)
10/23/2012 9:32:55 AM
More...
|
MultiCell Technologies Inc. (MCET.OB) to Announce Positive Preclinical Results at 2012 American Society for Cell Biology Meeting
9/27/2012 9:51:33 AM
More...
|
Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies Inc. (MCET.OB)
9/6/2012 12:12:45 PM
More...
|
MultiCell Technologies Inc. (MCET.OB) Announces Results of Shareholders' Meeting
8/15/2012 10:30:32 AM
More...
|
MultiCell Technologies Inc. (MCET.OB) Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in Vitro Models
8/10/2012 9:52:23 AM
More...
|
MultiCell Technologies Inc. (MCET.OB) Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in Vitro Models
5/16/2012 9:56:17 AM
More...
|
MultiCell Technologies Inc. (MCET.OB) Receives Final Payment Under QTDP Program
1/3/2012 10:22:49 AM
More...
|
MultiCell Technologies Inc. (MCET.OB) and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment
7/11/2011 7:19:30 AM
More...
|
|